Novo Obesity Shot Wegovy Helped Alcoholics Drink Less in Study

Novo Nordisk A/S’s obesity shot Wegovy helped people with alcoholism reduce their drinking, in the first controlled study of patients who sought help with their addiction.

Volunteers on Wegovy reported drinking heavily for five days in a 30-day period after six months of treatment, 12 fewer days than before they started. The improvement showed in other measures of addiction, such as total alcohol consumption and bloodwork.

“This was totally the dream scenario,” said Mette Kruse Klausen, a doctor and researcher at the Mental Health Center Copenhagen and one of the leaders of the study. “This is very robust results ...